Treatment target in polycythemia vera.
作者信息
Prchal Josef T, Gordeuk Victor R
出版信息
N Engl J Med. 2013 Apr 18;368(16):1555-6. doi: 10.1056/NEJMc1301262.
PMID:23594015
Abstract
摘要
相似文献
1
Treatment target in polycythemia vera.
N Engl J Med. 2013 Apr 18;368(16):1555-6. doi: 10.1056/NEJMc1301262.
2
Treatment target in polycythemia vera.
N Engl J Med. 2013 Apr 18;368(16):1556. doi: 10.1056/NEJMc1301262.
3
Treatment target in polycythemia vera.
N Engl J Med. 2013 Apr 18;368(16):1554-5. doi: 10.1056/NEJMc1301262.
4
Treatment target in polycythemia vera.
N Engl J Med. 2013 Apr 18;368(16):1555. doi: 10.1056/NEJMc1301262.
5
Treatment target in polycythemia vera.
N Engl J Med. 2013 Apr 18;368(16):1556-7. doi: 10.1056/NEJMc1301262.
6
Polycythemia vera, the hematocrit, and blood-volume physiology.
N Engl J Med. 2013 Jan 3;368(1):76-8. doi: 10.1056/NEJMe1213283. Epub 2012 Dec 8.
7
Cardiovascular events and intensity of treatment in polycythemia vera.
N Engl J Med. 2013 Jan 3;368(1):22-33. doi: 10.1056/NEJMoa1208500. Epub 2012 Dec 8.
8
Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Haematologica. 2017 Jan;102(1):103-109. doi: 10.3324/haematol.2016.152769. Epub 2016 Sep 29.
9
Therapeutic options for essential thrombocythemia and polycythemia vera.
Semin Oncol. 2002 Jun;29(3 Suppl 10):10-5. doi: 10.1053/sonc.2002.33755.
10
Polycythemia vera.
Hematol Oncol Clin North Am. 2003 Oct;17(5):1191-210. doi: 10.1016/s0889-8588(03)00083-2.
引用本文的文献
1
Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera.
Fed Pract. 2022 May;39(Suppl 2):S43-S46. doi: 10.12788/fp.0243. Epub 2022 Mar 16.
2
Red blood cells in thrombosis.
Blood. 2017 Oct 19;130(16):1795-1799. doi: 10.1182/blood-2017-03-745349. Epub 2017 Aug 15.
3
Experience with ruxolitinib in the treatment of polycythaemia vera.
Ther Adv Hematol. 2017 Apr;8(4):139-151. doi: 10.1177/2040620717693972. Epub 2017 Apr 1.
4
Ruxolitinib versus standard therapy for the treatment of polycythemia vera.
N Engl J Med. 2015 Jan 29;372(5):426-35. doi: 10.1056/NEJMoa1409002.
5
Optimal therapy for polycythemia vera and essential thrombocythemia can only be determined by the completion of randomized clinical trials.
Haematologica. 2014 Jun;99(6):945-9. doi: 10.3324/haematol.2014.106013.
Zotero 插件